Cyclophosphamide
Product Images NDC 82943-100

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Cyclophosphamide (NDC 82943-100). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nevakar Injectables Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Cyclophosphamide-inj-2.5ml (Cyclophosphamide Inj 25ml)

Label for Cyclophosphamide Injection 500 mg/2.5 mL (200 mg/mL) in a multiple-dose vial. The label includes a warning to dilute before intravenous use and states it is a hazardous drug. Storage instructions specify refrigeration at 2° to 8°C (36° to 46°F). Distributed by Nevakar Injectables Inc.*

FDA Label Image

Cyclophosphamide-inj-5ml (Cyclophosphamide Inj 5ml Ny)

Label for Cyclophosphamide Injection 1,000 mg/5 mL (200 mg/mL) by Nevakar Injectables Inc. It indicates the product is an injectable hazardous drug in multiple-dose vial form, requiring dilution before intravenous use. The label includes storage instructions to refrigerate at 2° to 8°C (36° to 46°F).*

FDA Label Image

Cyclophosphamide-structure (Cyclophosphamide Structure)

Chemical structure of cyclophosphamide, showing a cyclic ring with phosphorus and oxygen atoms, an amide group, and two 2-chloroethyl side chains, along with a water molecule indicating the hydrate form.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.